Condensed Consolidated Statements of Operation (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue	$ 0	$ 0
Cost of revenue	(6,000)	0
Gross profit	6,000	0
Operating expenses:
Research and development	258,180	187,457
General and administrative	519,831	497,703
Sales and marketing	89,560	77,385
Total operating expenses	867,571	762,545
Loss from operations	(861,571)	(762,545)
Other income (expense)
Interest expense	(98,971)	(56,581)
Change in fair value of derivative and warrant liabilities	(2,082,640)	(1,116,019)
Amortization of derivative and warrant liabilities discount	(150,733)	(464,068)
Amortization of deferred debt issuance costs and original issue discount	(47,124)	(190,569)
Loss on extinguishment of debt	0	(30,796)
Other income (expense), net	(9,118)	(2,518)
Nonoperating Income (Expense)	(2,388,586)	(1,860,551)
Net loss	$ (3,250,157)	$ (2,623,096)
Basic and diluted loss per share	$ (0.02)	$ (0.02)
Weighted average common shares outstanding:
Basic and diluted	167,208,694	155,871,102